samedan logo
 
 
 
spacer
home > ebr > spring 2004 > allergen microarrays: a novel tool for improved target discovery and individualised therapy
PUBLICATIONS
European Biopharmaceutical Review

Allergen Microarrays: A Novel Tool for Improved Target Discovery and Individualised Therapy

In recent years, protein microarrays have emerged as a key novel technology in the field of proteomics. Based on the concept of miniaturised ligand interaction assays, microarray-based immunological tests bear a great potential for high-throughput-based protein profiling, target finding and diagnostic applications. The use of allergens in recombinant and purified form has brought with it the introduction of allergen-specific IgE testing to the microarray format. Here, we discuss the application of microarray-based allergen profiling in the field of allergy vaccine development and its resulting impact on state-of-the-art diagnostic approaches.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Chistian Harwanegg, Senior Scientist, Proteomics and Reinhard Hiller, Head of Proteomics at VBC-GENOMICS Bioscience Research LLC

Dr Christian Harwanegg studied Genetics at the University of Vienna and received his PhD for the development of protein microarrays for allergy diagnosis in 2003. He is currently working as a Senior Scientist at VBC-GENOMICS Bioscience Research LLC, focusing on the implementation of new technologies for the company's protein biochip programme. Dr Harwanegg is also responsible for the software and assay automation development programme for the diagnostic biochip department.


Dr Reinhard Hiller is Head of the Proteomics Department at VBC-GENOMICS Bioscience Research LLC. In his current position he is responsible for the protein biochip development programme, including the approval of the allergen microarray as the first protein biochip-based IVD product in the EU, and conducting the marketing activities of the company's biochip applications. Dr Hiller joined VBC-GENOMICS in 2000, after receiving his PhD in Molecular Biology from the University of Vienna.

spacer
Dr Christian Harwanegg
spacer
spacer
spacer
Dr Reinhard Hiller
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Shionogi Announces Publication of Two Studies in The Lancet Infectious Diseases Highlighting The Efficacy And Safety of Cefiderocol For The Treatment of Infections Due to Aerobic Gram-Negative Bacteria in Adults With Limited Treatment Options

Shionogi announces publication of data from two of its clinical trials; APEKS-NP and CREDIBLE-CR in the journal The Lancet Infectious Diseases.
More info >>

White Papers

Modular Feeding Systems for Prefilled Syringes and Injection Devices

Dividella

The pre-filled syringe and injection device is an increasingly attractive presentation for both new and established parenteral pharmaceuticals. We will explore how innovative carton packaging solutions can enhance this presentation whilst meeting the stringent requirements of product protection.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement